Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better?: Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

Hyosun Kim’s report "Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A content Analysis of FDA Warning Letters" aims to teach marketers how to avoid breaching current Food and Drug Administration (FDA) guidelines in their online drug promotion. While Kim hopes to mi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Health Policy Manag
Hoofdauteur: Doran, Evan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Kerman University of Medical Sciences 2016
Onderwerpen:
Commentary
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4852004/
https://ncbi.nlm.nih.gov/pubmed/27239884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2016.20
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items